HIV & Aging
HIV & Aging
IAS 2013: Conference Opens with Focus on Aging, Global Guidelines, Drug Users
- Details
- Category: HIV Treatment
- Published on Sunday, 30 June 2013 00:00
- Written by Liz Highleyman
The 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) kicked off Sunday in Kuala Lumpur, Malaysia. Highlights of the first day included the release of new World Health Organization (WHO) antiretroviral therapy guidelines, a high-level panel on drug policy and public health, and a keynote address on HIV and aging.
IAS 2013: Management of Age-Related Conditions Is the Future of HIV Care
- Details
- Category: HIV Treatment
- Published on Sunday, 30 June 2013 00:00
- Written by Liz Highleyman
Other diseases are becoming far more important than AIDS for people with HIV who have consistent access and good response to antiretroviral treatment, and management of age-related comorbidities will become an increasingly important aspect of HIV medicine worldwide in the coming years, Steven Deeks argued in his keynote address yesterday at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013).
IAS 2013: HIV, Inflammation, and Aging [VIDEO]
- Details
- Category: HIV Treatment
- Published on Sunday, 30 June 2013 00:00
- Written by Gregory Fowler
HIV has become a chronic disease for people who have access and respond to antiretroviral therapy, but it leads to persistent immune activation and inflammation that could cause problems as people with HIV reach their 60s, 70s, and 80s, Steven Deeks from the University of California at San Francisco said in a keynote address at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.
IAS 2013: HIV as a Chronic Disease [VIDEO]
- Details
- Category: HIV Treatment
- Published on Sunday, 30 June 2013 00:00
- Written by Gregory Fowler
HIV has become a chronic disease for people who have access and respond to antiretroviral therapy, but it leads to persistent immune activation and inflammation that could cause problems as people with HIV reach their 60s, 70s, and 80s, Steven Deeks from the University of California at San Francisco explained at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.
Bone Loss and Fracture Risk are 'Modest' among HIV+ People, Linked to Tenofovir, Smoking, and HCV
- Details
- Category: Bone Loss
- Published on Thursday, 06 June 2013 00:00
- Written by Liz Highleyman
Continued bone loss among HIV positive men with osteopenia was modest overall, but about 25% of those taking tenofovir (Viread, also in 4 antiretroviral coformulations) experienced significant loss, according to a recent study. A related meta-analysis found that HIV infection is associated with a modest likelihood of new fractures, with smoking and hepatitis C virus (HCV) coinfection further increasing the risk.
Web Design and Development by